Josh Caddy

820 total citations
7 papers, 43 citations indexed

About

Josh Caddy is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Josh Caddy has authored 7 papers receiving a total of 43 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 3 papers in Genetics and 3 papers in Oncology. Recurrent topics in Josh Caddy's work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CAR-T cell therapy research (2 papers). Josh Caddy is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CAR-T cell therapy research (2 papers). Josh Caddy collaborates with scholars based in United Kingdom and Switzerland. Josh Caddy's co-authors include Andrew McMillan, Tom Maishman, Sharon Barrans, Andrew Davies, Louise Stanton, Peter Johnson, Cathy Laver‐Bradbury, Judy Hutchings, David Coghill and Thomas Cummin and has published in prestigious journals such as Blood, Laboratory Investigation and Trials.

In The Last Decade

Josh Caddy

6 papers receiving 43 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Josh Caddy United Kingdom	4	29	20	13	9	8	7	43
Sirin Khajavian United States	4	20 0.7×	19 0.9×	33 2.5×	16 1.8×	12 1.5×	5	67
John F. de Groot United States	3	11 0.4×	11 0.6×	16 1.2×	2 0.2×	9 1.1×	3	60
Bonaventura Casanova Estruch Spain	6	37 1.3×	8 0.4×	5 0.4×		3 0.4×	16	72
Sophy Denker Germany	4	23 0.8×	20 1.0×	10 0.8×			5	35
Melissa Ortega United States	4	57 2.0×	13 0.7×	8 0.6×	2 0.2×	1 0.1×	11	83
Victoria A. Chang United States	5	6 0.2×	33 1.6×	13 1.0×	1 0.1×	3 0.4×	8	67
Laura Navarro-Cantó Spain	6	81 2.8×	37 1.9×	1 0.1×	7 0.8×	9 1.1×	10	106
Marleen Borms Belgium	5	2 0.1×	24 1.2×	9 0.7×	3 0.3×	9 1.1×	10	67
J. Petrucci France	4	5 0.2×	9 0.5×	6 0.5×	5 0.6×	7 0.9×	5	30
Kyle Hitscherich United States	5	7 0.2×	11 0.6×	5 0.4×	1 0.1×	8 1.0×	14	66

Countries citing papers authored by Josh Caddy

Since Specialization

Citations

This map shows the geographic impact of Josh Caddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josh Caddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josh Caddy more than expected).

Fields of papers citing papers by Josh Caddy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josh Caddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josh Caddy. The network helps show where Josh Caddy may publish in the future.

Co-authorship network of co-authors of Josh Caddy

This figure shows the co-authorship network connecting the top 25 collaborators of Josh Caddy. A scholar is included among the top collaborators of Josh Caddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josh Caddy. Josh Caddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Davies, Andrew, Josh Caddy, Robert Waugh, et al.. (2022). Durable Responses from Acalabrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP) As First Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL): The Accept Phase Ib/II Single Arm Study. Blood. 140(Supplement 1). 9478–9479. 2 indexed citations

Wilding, Sam, Louise Stanton, Josh Caddy, et al.. (2022). Quality of Life Trajectories in Patients Treated with R-CHOP for Diffuse Large B-Cell Lymphoma As Part of the Remodl-B Trial (ISRCTN 51837425). Blood. 140(Supplement 1). 6648–6649.

Davies, Andrew, Josh Caddy, Louise Stanton, et al.. (2020). Acalabrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP) As First Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL): The Accept Phase Ib/II Single Arm Study. Blood. 136(Supplement 1). 38–39. 3 indexed citations

Cucco, Francesco, Alexandra Clipson, Hannah Kennedy, et al.. (2018). Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality. Laboratory Investigation. 98(8). 1084–1092. 6 indexed citations

Davies, Andrew, Ming Wang, Ming‐Qing Du, et al.. (2015). Real-Time Molecular Classification of Diffuse Large B-Cell Lymphoma (DLBCL) By Gene Expression Profiling (GEP): Successful Delivery of a Routine Service for Randomization of Patients Onto the Multicenter Remodl-B Trial (ISRCTN 51837425). Blood. 126(23). 331–331. 1 indexed citations

Davies, Andrew, Josh Caddy, Tom Maishman, et al.. (2015). A Prospective Randomised Trial of Targeted Therapy for Diffuse Large B-Cell Lymphoma (DLBCL) Based upon Real-Time Gene Expression Profiling: The Remodl-B Study of the UK NCRI and SAKK Lymphoma Groups (ISRCTN51837425). Blood. 126(23). 812–812. 21 indexed citations

McCann, Donna, Margaret Thompson, David Daley, et al.. (2014). Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD. Trials. 15(1). 142–142. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact